Company profile
Aparito company profile
Aparito’s mission is to digitise clinical trials and accelerate drug development by supporting patient-centric clinical trials with the Atom5™ eCOA platform. The Atom5™ platform is Part 11, GDPR and HIPPA compliant and supports clinical trials at scale with video eCOAs, ePROs, Wearables, Telemedicine and eConsent in 193 countries and 125 languages to capture more frequent patient-generated data in the clinic and at home. This moves from relying on sterile, snapshot assessments during clinic visits to continuous, real-time, real-world data utilising novel eCOA and digital biomarkers.
Business identity
- Website
- https://www.aparito.com
- Contact email
- [email protected]
- Phone number
- +44 1978 896 191
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2014-10-01
Headquarters
- Headquarters
- Wrexham, Wales, United Kingdom
- Postal code
- LL13 7YP
- Country code
- GB
- Continent
- Europe